|
|
|
|
|
| Sample: |
Palivizumab IgG monomer, 145 kDa Commercial (Synagis) protein
Anti-Idiotypic-Palivizumab-Nanobody1 monomer, 20 kDa Lama glama protein
|
| Buffer: |
PBS (137 mM NaCl, 2.7 mM KCl, 12 mM HPO4 2−/H2PO4 −), pH: 7.4
|
| Experiment: |
SAXS
data collected at EMBL P12, PETRA III on 2022 Sep 14
|
Respiratory syncytial virus (RSV)-approved monoclonal antibody Palivizumab as ligand for anti-idiotype nanobody-based synthetic cytokine receptors
Journal of Biological Chemistry :105270 (2023)
Ettich J, Wittich C, Moll J, Behnke K, Floss D, Reiners J, Christmann A, Lang P, Smits S, Kolmar H, Scheller J
|
| RgGuinier |
6.0 |
nm |
| Dmax |
20.4 |
nm |
|
